Share Price, page-11225

I reckon we will get a takeover offer at $25 and a lot of long suffering shareholders will say we will take the offer .

I am trying to convince myself $25 is a typo but seemingly not. I am incredulous.

I am not sure how long-term shareholders are 'suffering' when they are undoubtedly sitting on a heap of money from their investment. Talk about first-world problems and arrogance, These poor 'sufferers' should have sold out after PM results last year as it will be the pinnacle for Neuren and all the work done by Jon and the team this year has been a waste of time as it will not eventuate in anything more than what we all had in December last year? Pitt Hopkins, Angelman, undisclosed indications be dammed?

It would also make Jon's references to Reata seem pathetic, he said he hoped Neuren had more than that. It would also make posters who have contributed so much to the forum like Hottod, the Professor, Kit1969 and quite a few others look foolish with their valuations and pipeline prophesies. Let alone amateurs like me who have tried to work things out.

I always hold out hope the world is not as dumb as I think it is, but big pharma offering $25 makes them total dumbarses for thinking they could pick up something like Neuren for the equivalent of a small packet of chips, and if the Neuren board sold it for $25, then I will go to my grave knowing the world is completely and utterly bonkers.

Say it ain't so.